Du är här

2016-02-10

Aqua Bio Technology: Aqua Bio Technology reports best fiscal year in company history for 2015

Aqua Bio Technology ASA today announced its preliminary financial results for
2015. A strong fourth quarter contributed to the Company's best fiscal year
in company history. Sales, financial results and cash position reached all
time high levels in 2015.

ABT's income for 2015 ended at NOK 38.9 million after a 73 percent revenue
growth from the 2014 income of NOK 22.5 million. The revenue growth in the
fourth quarter alone was 79 percent. The income development was in line with
expectations, based on contracts with ABT's U.S. based exclusivity partners.

EBITDA for 2015 ended at NOK 21.2 million, compared to NOK 5.8 million the
previous year. The 2015 EBITDA corresponds to a margin of 55 percent. For the
fourth quarter alone, the EBITDA margin was 61 percent. The Company's net
result for 2015 came in at NOK 15.0 million, against NOK 0.9 million the
previous year.

Aqua Bio Technology improved its cash holdings even further in the fourth
quarter, and enjoyed a strong cash position of NOK 42 million at year-end.

Based on the Company's strong cash position and profits, following an approved
audit of the 2015 financial results, it is the intention of the Board of
Directors to recommend a dividend of NOK 1,50 per share to its General
Assembly.

"Our financial flexibility in combination with our core expertise, which is
the commercialization of new bio technology, enables us to pursue a strategy
of expansion," said CEO Arvid Lindberg.

ABT has in 2015 assessed a number of biotechnology projects and companies in
its search for additional commercial partners. Moving into 2016, ABT
forecasts a number of technology in-licensing partnerships in the near
future.

"Through building a broader technology base, we will expand ABTs business
model and value creation potential going forward," Arvid Lindberg said.

For further information, please call Arvid Lindberg, CEO, telephone +47 9824
5410

Aqua Bio Technology (ABT) has launched several cosmetic ingredients used in
skin care products globally. The ingredient, based on the Company's unique,
marine technology and other technologies, have documented positive effects on
the skin. Skin care is the fastest growing segment in the cosmetics industry,
where ABT's ingredients have established a foothold. In addition to
ingredients from its own technology, ABT also commercializes
technologies/ingredients for partners, for use in novel skin care products.
Aqua Bio Technology is listed on the Axess market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

ABT Q4 2015 report in Norwegian
http://hugin.info/138686/R/1984907/727822.pdf
ABT Q4 2015 presentation
http://hugin.info/138686/R/1984907/727823.pdf
ABT Q4 2015 press release
http://hugin.info/138686/R/1984907/727824.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aqua Bio Technology via Globenewswire

HUG#1984907

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.